BioRestorative Therapies (BRTX) EBITDA Margin (QoQ) (2012 - 2025)
BioRestorative Therapies (BRTX) EBITDA Margin (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.01 Mn | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | -3.03 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | -523,378.00 |
| Sep 30, 2024 | 179,181.00 |
| Jun 30, 2024 | 896,989.00 |
| Mar 31, 2024 | 494,675.00 |
| Dec 31, 2023 | -657,528.00 |
| Sep 30, 2023 | -528,033.00 |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 10.81 Mn |
| Dec 31, 2022 | -11.06 Mn |
| Sep 30, 2022 | -938,549.00 |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | -3.41 Mn |
| Sep 30, 2021 | -2.24 Mn |
| Jun 30, 2021 | 5.99 Mn |
| Mar 31, 2021 | -7.86 Mn |